Also, erythropoietin doses were examined at baseline and each month after receiving cholecalciferol supplementation.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background: This study aimed to evaluate the effect of vitamin D (cholecalciferol) supplementation on erythropoietin doses in hemodialysis patients.
📊
Key Findings & Data:Methods: In this semi-experimental study, we enrolled chronic kidney disease patients undergoing hemodialysis, referred to Shahid Beheshti hospital in Babol, Iran in 2018.
💡
Conclusion & Impact:Also, erythropoietin doses were examined at baseline and each month after receiving cholecalciferol supplementation.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters
Abstract
Background: This study aimed to evaluate the effect of vitamin D (cholecalciferol) supplementation on erythropoietin doses in hemodialysis patients. Methods: In this semi-experimental study, we enrolled chronic kidney disease patients undergoing hemodialysis, referred to Shahid Beheshti hospital in Babol, Iran in 2018. All patients with concomitant serum levels of 25-hydroxyvitamin D less than 30 ng/mL and hemoglobin below 10 g/dL were enrolled. These patients were treated with the oral pearl of vitamin D for 12 weeks. Monthly levels of serum vitamin D and hemoglobin were measured. Also, erythropoietin doses were examined at baseline and each month after receiving cholecalciferol supplementation. A P-value
🔖
Cite This Article
HAJAHMADI, M., SORKHI, H., FIROZJAEİ, A. N., AKBARİ, R., NİKPOUR, M., PORNASROLLAH, M. (2022). The Effect of Vitamin D Supplementation on Erythropoietin Utilization in Hemodialysis Patients: A Semi-experimental Study. Turkish journal of nephrology (Online), Cilt: 31 - Sayı: 2, 177–182. https://ajindex.com/articles/612808
Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150
Levey AS, De Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference Report. Kidney Int. 2011;80(1):17-28. [CrossRef] 3. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis - a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53(6):915-920. [CrossRef] 4. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789- 1858. [CrossRef] 5. Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of chronic kidney disease in Iranian general population: a metaanalysis and systematic review. Ther Apher Dial. 2018;22(6):594- 599. [CrossRef] 6. Yang M, Fox CH, Vassalotti J, Choi M. Complications of progression of CKD. Adv Chronic Kidney Dis. 2011;18(6):400-405. [CrossRef] 7. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2002;162(12):1401-1408. [CrossRef] 8. Mikhail A, Brown C, Williams JA, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease. BMC Nephrol. 2017;18(1):345. [CrossRef] 9. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE. 2014;9(1):e84943. [CrossRef] 10. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Relationship between Hb level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin. 2006;22(10):1929-1937. [CrossRef] 11. Locatelli F, Pisoni RL, Combe C, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19(1):121-132. [CrossRef] 12. Ataei N, Hosseini M, Baikpour M, et al. Etiology and outcome of chronic kidney disease in Iranian children. Int J Pediatr